GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Sale Of Investment

Verici Dx (Verici Dx) Sale Of Investment : $0.00 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Verici Dx Sale Of Investment?

Verici Dx's sale of investment for the six months ended in Jun. 2023 was $0.00 Mil. It means Verici Dx gained $0.00 Mil from selling investments. Verici Dx's sale of investment for the trailing twelve months (TTM) ended in Jun. 2023 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2022 ), Verici Dx gained the same money from selling investments in Jun. 2023 ($0.00 Mil).

Verici Dx Sale Of Investment Historical Data

The historical data trend for Verici Dx's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Verici Dx Sale Of Investment Chart

Verici Dx Annual Data
Trend Dec20 Dec21 Dec22
Sale Of Investment
- - -

Verici Dx Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23
Sale Of Investment - - - - -

Verici Dx Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Verici Dx Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Verici Dx's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Verici Dx (Verici Dx) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Verici Dx PLC (OTCPK:VRCDF) » Definitions » Sale Of Investment
Comparable Companies
LSE:ABDX LSE:GDR LSE:GENI LSE:PRM LSE:LLAI LSE:AGL TMO DHR SHSE:603259 IQV IDXX A XSWX:LONN MTD ICLR LH ILMN DGX WAT EXAS
Traded in Other Exchanges
VRCI:UK
Address
19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
Website
https://www.vericidx.com
Verici Dx PLC is an immuno-diagnostics development company. The company is focused on developing diagnostics technologies which will help understand the outcomes of an organ transplant surgery. There are two products for clinical validation and commercialization: Clarava, which is a pre-transplant prognosis for the risk of early acute rejection; and Tuteva, a post-transplant diagnostic focused upon acute cellular rejection including sub-clinical rejection not being diagnosed through the current standard of care of rising serum creatine levels. The business of the Group comprises a single activity, that of the development of prognostic and diagnostic tests for kidney transplant patients.

Verici Dx (Verici Dx) Headlines

No Headlines